Firm at a glance
Persistence Capital Partners is a platform private equity firm founded in 2008, per its own website [S1].
What they buy
Based on publicly disclosed holdings, Persistence Capital Partners appears to concentrate its investment activity in the healthcare services sector [S3]. The firm’s portfolio consists exclusively of healthcare platforms as of early 2025, spanning fertility and reproductive health, community pharmacy, diabetes care, and medical aesthetics [S3]. This pattern suggests a deliberate focus on consumer-facing healthcare delivery models rather than diversified sector exposure.
Portfolio
Healthcare Services
The firm’s publicly listed portfolio includes four platform investments [S3]:
– **ANOVA FERTILITY & REPRODUCTIVE HEALTH** (platform)
– **Neighbourly Pharmacy** (platform)
– **LMC** (platform)
– **MEDSPA PARTNERS** (platform)
Recent activity (last 24 months)
No recent public transactions were surfaced in the available data for the 24-month period ending January 2025. The most recent public disclosure relates to the firm’s fund closing in November 2023 [S2].
How this firm fits a seller
Persistence Capital Partners may be a fit for healthcare services businesses seeking a buyer with demonstrated sector expertise and a platform-building approach. The firm closed a fund exceeding C$375 million in November 2023, indicating active capital deployment capacity as of that date [S2]. For owner-operators in healthcare delivery, particularly those in specialty clinical services or consumer health segments, the firm’s concentrated portfolio suggests familiarity with regulatory environments and operational models common to these verticals. The absence of recent public transaction announcements limits visibility into current acquisition pace or evolving sector preferences.
Sources
[S1] https://persistencecapital.com/about (as of 2025-01-10)
[S2] https://persistencecapital.com/news (as of 2023-11-09)
[S3] https://persistencecapital.com/portfolio (as of 2025-01-10)
Frequently asked questions
Does Persistence Capital Partners buy Healthcare Services businesses?
Yes, healthcare services represents the firm’s primary observable investment focus as of early 2025 [S3]. All four publicly listed portfolio companies operate in healthcare delivery segments including fertility services, community pharmacy, diabetes management, and medical aesthetics [S3].
What companies has Persistence Capital Partners acquired recently?
The firm’s publicly disclosed portfolio includes ANOVA FERTILITY & REPRODUCTIVE HEALTH, Neighbourly Pharmacy, LMC, and MEDSPA PARTNERS, all designated as platform investments [S3]. Specific acquisition dates for these holdings are not publicly available in the sourced materials.
Where is Persistence Capital Partners based and how big is the firm?
The firm was founded in 2008 [S1] and closed a fund exceeding C$375 million in November 2023 [S2]. Office location information was not available in publicly accessible sources as of January 2025.
Is Persistence Capital Partners still actively acquiring?
The firm closed a fund exceeding C$375 million in November 2023 [S2], which typically indicates active investment capacity. However, no public transaction announcements were identified in the 24 months preceding January 2025, limiting visibility into current acquisition activity.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.